期刊文献+

凝血指标在系统性红斑狼疮疾病中的临床应用 被引量:3

Clinical Application of Coagulation Indexes in Systemic Lupus Erythematosus
下载PDF
导出
摘要 目的:检测系统性红斑狼疮(SLE)患者外周血中凝血指标及其相关指标来评价临床意义。方法:选用46例SLE患者为观察组,其中活动组26例,非活动组20例;40例正常人为对照组。测定血浆凝血酶原时间(PT),活化部分凝血活酶时间(APTT),血浆纤维蛋白原(FIB)和凝血酶时间(TT),血浆D-二聚体(D-Dimer,D-D)和纤维蛋白(原)降解产物(FDP),血浆抗凝血酶活性(AT:A);其他实验相关指标C反应蛋白(CRP),血沉(ESR)。结果:SLE组D-D及FDP明显高于对照组,PT及APTT比对照组明显缩短(均P<0.01),其他各指标均无统计学意义;SLE活动组ESR、CRP、D-D明显高于非活动组(均P<0.01),而FDP差别无统计学意义。结论:D-D及凝血指标能及时反映SLE患者体内凝血和纤溶系统失衡情况,对于SLE病程发展和控制有其重要的临床指导价值。 Objective Assess the clinical significance of coagulation and related indexes in patients with systemic lupus erythematosus. Method 46 patients with SLE(26 with active period and 20 with inactive period) and 40 normal subjects as control were studied. PT, AP3T,FIB,TT,AT:A,D-Dimer,FDP, CRP, ESR were detected. Results D-Dimer,FDP of SLE patients were much higher than those in the normal control, meanwhile PT and APTT showed shorter obviously. These differences which described above had statistical significance (P 〈 0.01 ). Plasma D-Dimer, ESR and CRP levels of SLE patients with active period were much higher than those in inactive period. Conclusion Plasma D-Dimer and levels of coagulation indexes can reflect the imbalance of coagulation-fibrinolytic system in patients with SLE, furthermore they might play an important role in efficient prediction and controlling of happening of SLE.
出处 《放射免疫学杂志》 CAS 2012年第1期54-56,共3页 Journal of Radioimmanology
关键词 系统性红斑狼疮 D-二聚体 凝血指标 systemic lupus erythematosus ( SLE), D-Dimer( D-D), coagulation indexes
  • 相关文献

参考文献4

二级参考文献22

  • 1窦春江,王晋平,居军,白兰乡.血浆同型半胱氨酸与系统性红斑狼疮关系的探讨[J].临床内科杂志,2005,22(4):265-267. 被引量:2
  • 2姜学义,峰下哲,韩春雷,杨学莉,汪整辉,寇丽筠,王黎曼,杨杰.系统性红斑狼疮患者纤溶功能测定[J].中华皮肤科杂志,1995,28(4):207-209. 被引量:5
  • 3朱铁楠 潘家琦.D-二聚体在血栓栓塞疾病中的应用[J].协和内科临床,2001,2(5):25-25.
  • 4Inoh M,Tokuda M,Kiuchi H,et al.Evaluating systemic lupus erythematosus diseaseactivity using molecular markers of hemostasis.Arthritis Rheum,1996 Feb,39(2)∶287-291.
  • 5Salazar paramo M, Garcia de la Torre l, Fritzler Mj,et al.Antibodies tofibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus areassociated with Raynaud's phenomenon and thrombosis. Lupus, 1996 Aug, 5(4)∶275-278.
  • 6Doria A, Ghirardello A, Boscaro M,et al.Fibrinolysis and coagulation abnormalitiesin systemic lupus erythematousus.Relationship with Raynaud's phenomenon, diseaseactivity,inflammatory indices,anticardiolipin and corticosteroid therapy.Rheumatolint,1995,14(5)∶207-211. (收稿:1999-07-06 修回:1999-10-11)
  • 7Liang M H,Socher S A Larson M G,et al.Reliability and validity of six systems for the clinical assessment of disease activity insystemic lupus erythematosus. Arthritis Rheum,1989,32(1)∶1107-110.
  • 8Schorer AE. Discordant effects on eicosanoid and fibrin degradati on products intwo murine models of antiphospholipid antibody.Thromb Res,1997 Feb, 85(4)∶295-304.
  • 9Atsumi T,Khamashta MA,Andujar C, et al. Elevated jplasma lipoprotein(a)level anits association with impaired fibrinolysis in patients with antiphospholipid syndrome.JRhematol,1998 Jan,25(1)∶69-70.
  • 10Hasselaar P,DerKsen RHWM,Blokzij L,et al.Rsik factors for thrombosis in lupus patients[J].Ann Rheum Dis,1989,48:933.

共引文献110

同被引文献31

  • 1许可见,刘跃华,蒋明.复发性多软骨炎的诊断和治疗[J].中国医学科学院学报,2007,29(2):171-173. 被引量:8
  • 2Vitale A, Sola J, Rigante D,Lopalco G, et al. Relapsingpolychondritis: an update on pathogenesis, clinical features,diagnostic tools, and therapeutic perspectives [ J ]. CurrRheumatol Rep,2016,18(1) :3.
  • 3Sharma A, Law AD, Bambery P, et al. Relapsingpolychondritis: clinical presentations, disease activity andoutcomes[J]. Orphanet J Rare Dis? 2014,9: 198.
  • 4McAdam LP? O'Hanlan MA, Bluestone R,et al. Relapsingpolychondritis j prospective study of 23 patients and a review ofthe literature[J]. Medicine, 1976,55(3) : 193-215.
  • 5Hazra N,Dregan A, Charlton J, et al. Incidence andmortality of relapsing polychondritis in the UK : a population-based cohort study [J]. Rheumatology (Oxford), 2015, 54(12):2181-2187.
  • 6Cantarini L,Vitale A,Brizi MG, et al. Diagnosis andclassification of relapsing polychondritis CJ]. J Autoimmun,2014,48-49:53-59.
  • 7Hoppe B? Dorner T. Coagulation and the fibrin network inrheumatic disease: a role beyond haemostasis [J]. Nat RevRheumatol, 2012, 8(12): 738-746.
  • 8Bloom BJ? Alario AJ, Miller LC. Persistent elevation of fibrinD-dimer predicts longterm outcome in systemic juvenileidiopathic arthritis[J]. J Rheumatol, 2009,36(2) : 422-426.
  • 9Divecha H,Sattar N, Ruinley A, et al. Cardiovascular riskparameters in men with ankylosing spondylitis in comparisonwith non-inflammatory control subjects: relevance of systemicinflammation[J]. Clin Sci (Lond) ? 2005,109(2) . 171-176.
  • 10赵征,黄烽.调控纤维蛋白水平对炎性疾病的影响及潜在应用价值[J].军医进修学院学报,2008,29(1):70-71. 被引量:1

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部